UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Nature communications, 2019-12, Vol.10 (1), p.5499-14, Article 5499

2019

Volltextzugriff (PDF)

Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018

Breast care (Basel, Switzerland), 2022-10, Vol.17 (5), p.486-494

2022

Volltextzugriff (PDF)

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer

EMBO molecular medicine, 2016-09, Vol.8 (9), p.1052-1064

2016

Volltextzugriff (PDF)

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4662-4670

2017

Volltextzugriff (PDF)

DNA methylation at enhancers identifies distinct breast cancer lineages

Nature communications, 2017-11, Vol.8 (1), p.1379-14, Article 1379

2017

Volltextzugriff (PDF)

The Norwegian Breast Cancer Registry (NBCR): A clinical register that monitors surgical care with the intention to increase the quality of treatment given to breast cancer patients in Norway

Norsk epidemiologi, 2022-10, Vol.30 (1-2)

2022

Volltextzugriff (PDF)

Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions

JMIR research protocols, 2023-05, Vol.12, p.e47195-e47195

2023

Volltextzugriff (PDF)

Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes

Heliyon, 2024-07, Vol.10 (13), p.e32529, Article e32529

2024

Volltextzugriff (PDF)

Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women

European journal of surgical oncology, 2023-03, Vol.49 (3), p.575-582

2023

Volltextzugriff (PDF)

Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study

European journal of surgical oncology, 2024-02, Vol.50 (2), p.107938-107938, Article 107938

2024

Volltextzugriff (PDF)

Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women

European journal of nutrition, 2022

2022

Volltextzugriff (PDF)

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer

Genome medicine, 2021-04, Vol.13 (1), p.72-21, Article 72

2021

Volltextzugriff (PDF)

The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers

Scientific reports, 2020-01, Vol.10 (1), p.1277-1277, Article 1277

2020

Volltextzugriff (PDF)

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

International journal of cancer, 2020-11, Vol.147 (9), p.2515-2525

2020

Volltextzugriff (PDF)

Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery

British journal of nutrition, 2021-01, Vol.125 (2), p.172-182

2021

Volltextzugriff (PDF)

Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery

British journal of nutrition, 2021

2021

Volltextzugriff (PDF)

Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analytics

Breast cancer research and treatment, 2023-09, Vol.201 (2), p.247-256

2023

Volltextzugriff (PDF)

Surgical treatment of breast cancer in Norway 2003–2018

Tidsskrift for den Norske Lægeforening, 2020-10

2020

Volltextzugriff (PDF)

Abstract OT2-19-01: Presurgical treatment with ribociclib and letrozole in patients with locally advanced breast cancer: The NEOLETRIB study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-19-01-OT2-19-01

2022

Volltextzugriff (PDF)

Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women

European journal of nutrition, 2022-12, Vol.61 (8), p.3873-3885

2022

Volltextzugriff (PDF)

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer

Breast cancer research and treatment, 2017-02, Vol.162 (1), p.127-137

2017

Volltextzugriff (PDF)

Kirurgisk behandling av brystkreft i Norge 2003-2018

Tidsskrift for den Norske Lægeforening, 2020, Vol.140 (15)

2020

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Breast Cancer
(20)
Life Sciences & Biomedicine
(20)
Humans
(16)
Female
(15)
Gene Expression
(12)
Oncology
(10)
Tumors
(10)
Middle Aged
(8)
Surgery
(8)
Breast Neoplasms - Genetics
(7)
Breast Neoplasms - Pathology
(7)
Cancer
(7)
Multidisciplinary Sciences
(7)
Patients
(7)
Science & Technology - Other Topics
(7)
Dna Methylation
(5)
Gene Expression Regulation, Neoplastic
(5)
Genomes
(5)
Prognosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

DNA methylation at enhancers identifies distinct breast cancer lineages

The Norwegian Breast Cancer Registry (NBCR): A clinical register that monitors surgical care with the intention to increase the quality of treatment given to breast cancer patients in Norway

Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions

Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women

Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study

Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer

The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery

Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery

Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analytics

Surgical treatment of breast cancer in Norway 2003–2018

Abstract OT2-19-01: Presurgical treatment with ribociclib and letrozole in patients with locally advanced breast cancer: The NEOLETRIB study

Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer

Kirurgisk behandling av brystkreft i Norge 2003-2018

The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer

Suchergebnisse filtern